BIOLIGANDS ApS: Financial statements 2022
CVR: 26603110
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
BIOLIGANDS ApS (CVR 26603110) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -4,652 and a net result of DKK -5,323 compared with DKK -4,363 the year before. Equity in the 2022 report amounted to DKK 79,023. The solvency ratio was 96.9%.
- Gross Profit
- DKK -4,652
- Profit/Loss
- DKK -5,323
- Equity
- DKK 79,023
- Total Assets
- DKK 81,523
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5 t. | -5 t. | 79 t. | - |
| 2021 | - | -4 t. | -4 t. | 84 t. | - |
| 2020 | - | -5 t. | -5 t. | 89 t. | - |
| 2019 | - | -3 t. | -3 t. | 93 t. | - |
| 2018 | - | -7 t. | -7 t. | 96 t. | - |
Official annual report
Keep an eye on BIOLIGANDS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOLIGANDS ApS
BIOLIGANDS ApS is a Danish company of the type Anpartsselskab based in Odense SV, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named BIOLIGANDS ApS UNDER STIFTELSE. The management consists of Esben Nørgaard Flindt. The board consists of Rasmus Koefoed Petersen. The company's owners include Esben Nørgaard Flindt, Karsten Kristiansen and Hongbin Zhang. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -8,258 and a net result of DKK -7,129 compared with DKK -4,850 the year before. Equity in the 2025 report amounted to DKK 62,700.